Acelyrin gathers $120m Series B
Acelyrin, a clinical-stage biopharma company, has raised $250 million in Series B financing.
Acelyrin, a clinical-stage biopharma company, has raised $250 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination